Literature DB >> 1601675

Amino acids for the measurement of protein synthesis in vivo by PET.

W Vaalburg1, H H Coenen, C Crouzel, P H Elsinga, B Långström, C Lemaire, G J Meyer.   

Abstract

In principle, PET in combination with amino acids labelled with positron-emitting radionuclides and kinetic metabolic models, can quantify local protein synthesis rates in tissue in vivo. These PET measurements have clinical potential in, for example, oncology, neurology and psychiatry. An optimal positron-emitting amino acid for the measurement of PSR has a high protein incorporation, can easily be prepared by automated equipment and has minimal non-protein radioactive metabolites. Presently L-[methyl-11C]methionine, L-[1-11C]leucine, L-[1-11C]tyrosine, L-[1-11C]phenylalanine, L-[1-11C]methionine and L-[2-18F]fluorotyrosine are under evaluation in normal volunteers and/or in patients. Several other amino acids are suggested. No comparison of the clinical usefulness of the different amino acids in man is yet available. Because of the longer half life of 18F compared to 11C, [18F]fluoro amino acids may have advantages over [11C]amino acids for the investigation of tissue with relative slow protein synthesis, such as brain, and for application in institutions with an off site, but nearby cyclotron. The half life of [13N]amino acids is considered to be too short for flexible clinical application. As yet no metabolic compartmental model has been investigated for [13N]amino acids. For routine application reliable preparation of the radiopharmaceutical is essential. Of all the amino acids under evaluation, a reliable, high yield, easy to automate production procedure is available for L-[methyl-11C]methionine only. It is however unlikely that this tracer can accurately measure PSR because of its non-protein metabolism. For the other amino acids the main problems in production are associated with complex multistep syntheses and/or low radiochemical yields, complex purification methods and the need to isolate the L-enantiomer. The kinetic metabolic models under investigation, consist of 4 or 5 compartments depending on the necessity to compensate for labelled metabolites. The metabolic profile of the amino acids is mainly extracted from animal experiments. Because of the number and amount of labelled metabolites in plasma, [11C]carboxylic labelled amino acids are preferred to amino acids with carbon-11 in another position. As yet no recommendation can be given on the optimal labelled amino acid(s) for PSR measurement in vivo nor on the methods to prepare the amino acids reported for this purpose.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1601675     DOI: 10.1016/0883-2897(92)90011-m

Source DB:  PubMed          Journal:  Int J Rad Appl Instrum B        ISSN: 0883-2897


  13 in total

1.  Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy.

Authors:  M Würker; K Herholz; J Voges; U Pietrzyk; H Treuer; B Bauer; V Sturm; W D Heiss
Journal:  Eur J Nucl Med       Date:  1996-05

Review 2.  Tracers for metabolic imaging of brain and heart. Radiochemistry and radiopharmacology.

Authors:  G Stöcklin
Journal:  Eur J Nucl Med       Date:  1992

3.  Comparative enzymology of (2S,4R)4-fluoroglutamine and (2S,4R)4-fluoroglutamate.

Authors:  Arthur J L Cooper; Boris F Krasnikov; John T Pinto; Hank F Kung; Jianyong Li; Karl Ploessl
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2012-05-19       Impact factor: 2.231

4.  Application of a Small Molecule Radiopharmaceutical Concept to Improve Kinetics.

Authors:  Jae Min Jeong
Journal:  Nucl Med Mol Imaging       Date:  2015-09-28

5.  Hepatic metabolism of 11C-methionine and secretion of 11C-protein measured by PET in pigs.

Authors:  Jacob Horsager; Susanne Bach Lausten; Dirk Bender; Ole Lajord Munk; Susanne Keiding
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-09-01

6.  Evaluation of D-isomers of O-18F-fluoromethyl, O-18F-fluoroethyl and O-18F-fluoropropyl tyrosine as tumour imaging agents in mice.

Authors:  Hideo Tsukada; Kengo Sato; Dai Fukumoto; Takeharu Kakiuchi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05-13       Impact factor: 9.236

7.  Synthesis and evaluation of 18F labeled alanine derivatives as potential tumor imaging agents.

Authors:  Limin Wang; Zhihao Zha; Wenchao Qu; Hongwen Qiao; Brian P Lieberman; Karl Plössl; Hank F Kung
Journal:  Nucl Med Biol       Date:  2012-04-26       Impact factor: 2.408

Review 8.  Fluorinated tracers for imaging cancer with positron emission tomography.

Authors:  Olivier Couturier; André Luxen; Jean-François Chatal; Jean-Philippe Vuillez; Pierre Rigo; Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-06       Impact factor: 9.236

9.  Diagnostics of cerebral gliomas with radiolabeled amino acids.

Authors:  Karl-Josef Langen; Klaus Tatsch; Anca-Ligia Grosu; Andreas H Jacobs; Matthias Weckesser; Osama Sabri
Journal:  Dtsch Arztebl Int       Date:  2008-01-25       Impact factor: 5.594

10.  SPECT and PET imaging of meningiomas.

Authors:  Varvara Valotassiou; Anastasia Leondi; George Angelidis; Dimitrios Psimadas; Panagiotis Georgoulias
Journal:  ScientificWorldJournal       Date:  2012-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.